Clinical Trials Browser

Phase 2 × Neuroblastoma × antineoplaston AS 2-1 × Clear all

NCT00003513 2017-09-28

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma

Phase 2 Terminated

Neuroblastoma